Home / Expertise / Intellectual Property / Patent Attorneys

Patent Attorneys

United Kingdom

The CMS patent attorney practice disrupts the traditional boutique approach to provide a service that meets the needs of modern business practice.  

Using proven, robust and efficient processes to manage portfolios through the patenting process, we pour care and attention into every detail, whether a portfolio’s value comes from its size or from the key nature of one or a small number of cases.

This is a people business, and we invest time in understanding the individuals we work with and their organisations.  Our clients’ patent portfolios are under constant scrutiny and clients’ need to know they are in the very best hands.  Our attorneys have long-held passions for the sectors we work in, with many having PhDs and / or industry experience in their chosen area. Always seeking to do things better, we have a culture of challenging each other and questioning how we work. This leads to constant improvements and the best solutions for each client.

The CMS Patent Attorney practice is also delighted to have been recognised in:

  • Tier 1: UK Legal 500 PATMA: Patent Attorneys, 2021
  • Tier 1: UK Legal 500 Life Sciences & Healthcare, 2021
  • Tier 1: UK Legal 500 IT and Telecoms, 2021 
  • Recommended for patent prosecution – IAM Patent 1000, 2020
  • Recommended in UK Financial Time’s ‘Europe’s Leading Patent Law Firms’, 2020

Located as a part of a global law firm, we have immediate access to the broader legal perspective and an improved ability to understand and assess the risks associated with different strategies, further protecting our clients’ portfolios in the long term.

You can find out more about patent attorneys at CMS below:

 

 

 

Read more Read less

"Excellent industry and technical knowledge allied to in-depth knowledge of intellectual property law." Tier 1 PATMA: Patent Attorneys.

Legal 500, 2021
Pro­tect­ing in­nov­a­tion from start to fin­ish
Pat­ent At­tor­ney bro­chure

Feed

Show only
14 May 2021
Re­cord­ing an as­sign­ment at the European Pat­ent Of­fice
Doc­u­ment sign­ing has presen­ted nov­el chal­lenges in the new re­mote-work­ing en­vir­on­ment. Re­cord­ing an as­sign­ment at the European Pat­ent Of­fice (EPO) can be straight­for­ward provided that the form­al re­quire­ments...
23 March 2021
The En­larged Board of the European Pat­ent Of­fice has giv­en a mo­ment­ous...
The En­larged Board of the European Pat­ent Of­fice heard or­al ar­gu­ments in Ju­ly 2020 con­cern­ing pat­entab­il­ity of a com­puter soft­ware in­ven­tion.  This rare event was video streamed to over 1600 pat­ent stake­hold­ers...
05 March 2021
New EPO Guidelines on an­ti­body claims provide fur­ther clar­ity for ap­plic­ants
In­tro­duc­tion The EPO has now pub­lished their re­vised Guidelines for Ex­am­in­a­tion 2021[1] which con­tain new sec­tions de­tail­ing EPO prac­tice in re­la­tion to an­ti­bod­ies for the first time, en­ter­ing in­to force...
04 March 2021
In­ter­di­git­al Tech­no­logy v Len­ovo: should for­eign courts’ per­mis­sion be...
In In­ter­di­git­al Tech­no­logy Corp and oth­ers v Len­ovo Group Ltd and oth­ers [2021] EWHC 255 (Pat), Hacon HHJ, sit­ting as a Judge, ruled at a pre-tri­al re­view that pri­or ap­prov­al from the com­pet­ent au­thor­ity...
01 March 2021
Mad Dogg in a spin as Pelo­ton fight back
Des­pite some long over­due op­tim­ism ap­pear­ing on the ho­ri­zon, the pan­dem­ic has had a dev­ast­at­ing ef­fect on large parts of the eco­nomy. That said, whilst some sec­tors have found the go­ing in­cred­ibly tough...
24 February 2021
COV­ID and ViCo: EPO re­fer­ral to the En­larged Board of Ap­peal
In the last year, the COV­ID-19 pan­dem­ic has res­ul­ted in a large pro­por­tion of the leg­al sec­tor trans­ition­ing to a ‘work from home’ ar­range­ment, with meet­ings tak­ing place re­motely. Non-es­sen­tial travel...
22 February 2021
Up­date on UK Sup­ple­ment­ary Pro­tec­tion Cer­ti­fic­ates post-Brexit
In Decem­ber 2020, the UK In­tel­lec­tu­al Prop­erty Of­fice (“UKIPO”) pub­lished new guid­ance for the op­er­a­tion sup­ple­ment­ary pro­tec­tion cer­ti­fic­ates in the UK fol­low­ing Brexit. The new sup­ple­ment­ary pro­tec­tion...
22 February 2021
Colo­plast v Salts [2021] EWHC 3 (Pat) – is it in­vent­ive if the skilled...
On 21 Janu­ary 2021, Deputy High Court Judge Nich­olas Cad­dick Q.C. handed down judg­ment in pat­ent lit­ig­a­tion pro­ceed­ings between Colo­plast A/S (“Colo­plast”), the Claimant, and Salts Health­care Lim­ited...
16 February 2021
Fight­ing poor med­ic­a­tion ad­her­ence in the European Uni­on: The Grav­it­ate-Health...
Nowadays, European cit­izens can ob­tain a great amount of in­form­a­tion (on­line and off­line) about any medi­cine. However, this in­form­a­tion is in many cases un­re­li­able and dif­fi­cult to un­der­stand, en­cour­aging...
11 February 2021
New EPO Guidelines now pub­lished re­gard­ing amend­ing the de­scrip­tion: what’s...
In­tro­duc­tion In Oc­to­ber 2020, CMS pub­lished an art­icle ‘New EPO Guidelines ex­pec­ted re­gard­ing amend­ing a de­scrip­tion: what’s all the fuss about?’, which has been the cata­lyst for dis­cus­sion in the...
22 December 2020
Design dis­putes: com­batting copycats with a col­lec­tion of IP rights – Freddy...
On 19 Novem­ber 2020, the In­tel­lec­tu­al Prop­erty En­ter­prise Court (IPEC) handed down a de­cis­ive judg­ment in Freddy SPA v HUGZ Cloth­ing Ltd & Ors [2020] EM­HW 3032, which could see brand own­ers, es­pe­cially...
15 December 2020
Five years after Hua­wei ZTE FRAND li­cens­ing ob­lig­a­tions again be­fore the...
On 26 Novem­ber 2020, the Düs­sel­dorf Re­gion­al Court an­nounced that it would sus­pend a pat­ent in­fringe­ment pro­ceed­ing and refer key ques­tions on com­puls­ory li­cens­ing of stand­ard es­sen­tial pat­ents (SEP)...